Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
157.60
Jul 13 • 03:59PM ET Dollar change+3.18 Percentage change(2.06%)
Aftermarket Close
157.60
Aftermarket • 06:18PM ET Dollar change0.00 Percentage change(0.00%)
Jul 09, 8:35 AMICU Medical plans over $500 million expansion of Austin IV solutions manufacturing capacity to bolster North American supply
Index
RUT
Market Cap
3.94B
Enterprise Value
4.99B
Income
46.34M
Sales
2.16B
Book/sh
84.50
Cash/sh
11.54
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
13000
IPO
Mar 31, 1992
P/E
85.10
Forward P/E
17.00
PEG
1.82
P/S
1.83
P/B
1.87
P/C
13.66
P/FCF
47.63
EV/EBITDA
15.86
EV/Sales
2.31
Quick Ratio
1.13
Current Ratio
2.30
Debt/Eq
0.64
LT Debt/Eq
0.62
Option/Short
Yes / Yes
EPS (ttm)
1.85
EPS next Y
9.27
EPS next Q
1.91
EPS this Y
5.12%
EPS next Y
13.63%
EPS next 5Y
9.36%
EPS past 3/5Y
- -62.61%
Sales past 3/5Y
-0.68% 11.90%
EPS Y/Y TTM
148.96%
Sales Y/Y TTM
-10.76%
EPS Q/Q
289.73%
Sales Q/Q
-12.19%
Insider Own
1.92%
Insider Trans
-1.44%
Inst Own
103.29%
Inst Trans
-0.34%
ROA
1.13%
ROE
2.26%
ROIC
1.36%
Gross Margin
34.81%
Oper. Margin
5.09%
Profit Margin
2.15%
SMA20
6.79%
SMA50
15.53%
SMA200
15.61%
Trades
Shs Outstand
24.99M
Shs Float
24.51M
52W High
162.18 -2.82%
52W Low
107.00 47.29%
Volatility
3.68% 3.48%
ATR (14)
5.13
RSI (14)
64.49
Beta
0.76
Rel Volume
0.52
Avg Volume
298.86K
Volume
155,832
Perf Week
-1.15%
Perf Month
12.71%
Perf Quarter
25.40%
Perf Half Y
3.92%
Perf YTD
10.46%
Perf Year
19.25%
Perf 3Y
-13.52%
Perf 5Y
-22.73%
Perf 10Y
37.07%
Prev Close
154.42
Price
157.60
Change
2.06%
Date Action Analyst Rating Change Price Target Change
Jun-15-26Initiated BTIG Research Buy $170
May-27-26Upgrade Needham Hold → Buy $165
Aug-15-25Initiated Piper Sandler Overweight $145
Mar-12-25Upgrade Raymond James Outperform → Strong Buy $205 → $197
Dec-11-24Upgrade Jefferies Hold → Buy $200
Oct-14-24Initiated Jefferies Hold $183
Jun-21-24Initiated Needham Hold
Jun-17-24Upgrade Raymond James Mkt Perform → Outperform $135
Nov-08-22Downgrade Raymond James Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Jul-10-26 11:31AM
Jul-09-26 08:30AM
May-07-26 05:07PM
04:05PM
Apr-23-26 08:30AM
07:24PM Loading…
Mar-03-26 07:24PM
Feb-23-26 08:30AM
Feb-20-26 08:30AM
03:58AM
12:04AM
Feb-19-26 10:07PM
06:30PM
05:50PM
05:20PM
05:07PM
04:05PM Loading…
04:05PM
Feb-17-26 10:04PM
Feb-13-26 08:57PM
Feb-05-26 08:30AM
Jan-22-26 09:21PM
Jan-15-26 11:31PM
07:49AM
Dec-31-25 08:30AM
Dec-15-25 11:03PM
Nov-27-25 10:31PM
Nov-20-25 08:30AM
Nov-13-25 12:35AM
Nov-07-25 01:11PM
11:46AM
09:28AM
12:02AM Loading…
12:02AM
Nov-06-25 07:00PM
06:03PM
04:17PM
04:05PM
Nov-05-25 06:25PM
Nov-04-25 10:12PM
Oct-29-25 08:50AM
Oct-27-25 11:32PM
Oct-23-25 08:30AM
Sep-05-25 12:45PM
Sep-04-25 12:43AM
Sep-01-25 09:51AM
Aug-21-25 08:30AM
Aug-15-25 09:32AM
Aug-14-25 01:35AM
Aug-11-25 09:30AM
Aug-08-25 12:21PM
09:27AM
04:33AM
Aug-07-25 06:40PM
05:33PM
04:05PM
Aug-05-25 11:07PM
Aug-04-25 04:08AM
Jul-25-25 11:15AM
Jul-24-25 08:30AM
Jul-18-25 11:07AM
Jul-01-25 05:34AM
01:32AM
Jun-18-25 11:31PM
Jun-10-25 12:03AM
Jun-04-25 07:27AM
May-09-25 11:15AM
03:38AM
12:36AM
May-08-25 06:45PM
05:41PM
04:05PM
May-07-25 09:54AM
04:55AM
May-01-25 08:30AM
Apr-29-25 05:59AM
Apr-24-25 08:30AM
Apr-10-25 01:20PM
Apr-09-25 06:33AM
Apr-08-25 12:04PM
Apr-07-25 08:00AM
Mar-25-25 05:03AM
Mar-24-25 08:30AM
Mar-21-25 07:04AM
Mar-07-25 08:40AM
Mar-06-25 08:02AM
Mar-03-25 07:19PM
Feb-28-25 07:28AM
02:33AM
Feb-27-25 09:06PM
06:20PM
05:19PM
05:10PM
04:05PM
Feb-26-25 08:03AM
07:22AM
Feb-14-25 04:04AM
04:01AM
Feb-13-25 04:05PM
04:05PM
04:02AM
04:01AM
Jan-03-25 08:30AM
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
CEO & Chairman of the BoardMr. Vivek Jain
PresidentMr. Daniel Woolson
CFO & TreasurerMr. Brian Michael Bonnell
Chief Operating OfficerMr. Christian B. Voigtlander
Corporate VPMs. Virginia Ruth Sanzone
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DANIEL WOOLSONOfficerMay 22 '26Proposed Sale132.212,123280,685May 22 04:35 PM
Woolson DanielPresidentMay 22 '26Sale132.212,123280,68522,479May 22 03:47 PM
Sanzone Virginia RuthVP, General CounselMay 14 '26Sale124.082,447303,62419,460May 15 12:19 PM
VIRGINIA SANZONEOfficerMay 14 '26Proposed Sale124.082,447303,624May 14 06:48 PM
KENNEDY KOLLEEN TDirectorMay 13 '26Option Exercise0.001,25404,539May 13 09:29 PM
Hernandez LaurieDirectorMay 13 '26Option Exercise0.001,25404,862May 13 09:20 PM
FINNEY ELISHA WDirectorMay 13 '26Option Exercise0.001,25405,249May 13 09:11 PM
Abbey DonaldDirectorMay 13 '26Option Exercise0.001,25406,004May 13 08:52 PM
Hoffmeister David FDirectorMay 13 '26Option Exercise0.001,25406,004May 13 08:38 PM
Greenberg David C.DirectorMay 12 '26Option Exercise101.062,424244,96910,384May 13 08:31 PM
Greenberg David C.DirectorMay 13 '26Option Exercise0.001,25409,214May 13 08:31 PM
Greenberg David C.DirectorMay 12 '26Sale122.912,424297,9347,960May 13 08:31 PM
DAVID C GREENBERGDirectorMay 12 '26Proposed Sale122.912,424297,934May 12 05:39 PM
Voigtlander Christian B.Chief Operating OfficerMar 15 '26Option Exercise0.0014,648051,154Mar 16 04:34 PM
Woolson DanielVP, GM-Infusion CapitalMar 15 '26Option Exercise0.002,924025,897Mar 16 04:33 PM
Sousa BenChief Information OfficerMar 15 '26Option Exercise0.001,30006,044Mar 16 04:32 PM
Sanzone Virginia RuthVP, General CounselMar 15 '26Option Exercise0.007,324024,330Mar 16 04:31 PM
Jain VivekChairman and CEOMar 15 '26Option Exercise0.0021,9720134,106Mar 16 04:30 PM
Bonnell Brian MichaelChief Financial OfficerMar 15 '26Option Exercise0.0014,648076,097Mar 16 04:28 PM
Bonnell Brian MichaelChief Financial OfficerMar 08 '26Option Exercise0.0071,7570104,364Mar 09 04:32 PM
Bonnell Brian MichaelChief Financial OfficerMar 07 '26Option Exercise0.003,522033,870Mar 09 04:32 PM
Jain VivekChairman and CEOMar 08 '26Option Exercise0.00107,6350176,506Mar 09 04:21 PM
Jain VivekChairman and CEOMar 07 '26Option Exercise0.005,282071,790Mar 09 04:21 PM
Sousa BenChief Information OfficerMar 08 '26Option Exercise0.008,13408,283Mar 09 04:19 PM
Sousa BenChief Information OfficerMar 07 '26Option Exercise0.001,40901,888Mar 09 04:19 PM
Sanzone Virginia RuthVP, General CounselMar 08 '26Option Exercise0.0027,106030,424Mar 09 04:18 PM
Sanzone Virginia RuthVP, General CounselMar 07 '26Option Exercise0.002,34807,804Mar 09 04:18 PM
Woolson DanielVP, GM-Infusion CapitalMar 08 '26Option Exercise0.0018,300028,327Mar 09 04:15 PM
Woolson DanielVP, GM-Infusion CapitalMar 07 '26Option Exercise0.001,585012,882Mar 09 04:15 PM
Voigtlander Christian B.Chief Operating OfficerMar 08 '26Option Exercise0.0071,757079,421Mar 09 04:14 PM
Voigtlander Christian B.Chief Operating OfficerMar 07 '26Option Exercise0.003,52209,610Mar 09 04:14 PM
DANIEL WOOLSONOfficerNov 25 '25Proposed Sale152.352,897441,364Nov 25 04:09 PM
Woolson DanielVP, GM-Infusion CapitalNov 25 '25Sale152.352,897441,36411,297Nov 25 03:18 PM
FINNEY ELISHA WDirectorNov 11 '25Option Exercise103.761,285133,3325,280Nov 12 10:59 AM
FINNEY ELISHA WDirectorNov 11 '25Sale140.421,285180,4403,995Nov 12 10:59 AM
Sanzone Virginia RuthVP, General CounselNov 11 '25Sale142.34930132,3815,456Nov 12 10:55 AM
VIRGINIA SANZONEOfficerNov 11 '25Proposed Sale142.34930132,381Nov 12 10:27 AM
ELISHA W FINNEYDirectorNov 11 '25Proposed Sale140.421,285180,440Nov 12 09:05 AM
Greenberg David C.DirectorAug 27 '25Buy126.421,200151,6987,960Aug 27 05:51 PM
Jain VivekChairman and CEOAug 14 '25Buy112.8421,9292,474,375130,149Aug 14 07:07 PM
Last Close
1,299.53
Jul 13 • 03:59PM ET Dollar change+3.36 Percentage change(0.26%)
Aftermarket Close
1,299.53
Aftermarket • 06:18PM ET Dollar change0.00 Percentage change(0.00%)
MTD Mettler-Toledo International Inc daily Stock Chart
Index
S&P 500
Market Cap
26.26B
Enterprise Value
28.43B
Income
875.06M
Sales
4.09B
Book/sh
-2.07
Cash/sh
3.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
18100
IPO
Nov 14, 1997
P/E
30.48
Forward P/E
25.42
PEG
2.54
P/S
6.42
P/B
-
P/C
433.55
P/FCF
33.08
EV/EBITDA
22.67
EV/Sales
6.95
Quick Ratio
0.84
Current Ratio
1.20
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
42.64
EPS next Y
51.13
EPS next Q
10.79
EPS this Y
9.23%
EPS next Y
9.55%
EPS next 5Y
10.00%
EPS past 3/5Y
3.07% 11.04%
Sales past 3/5Y
0.90% 5.47%
EPS Y/Y TTM
6.19%
Sales Y/Y TTM
6.78%
EPS Q/Q
6.68%
Sales Q/Q
7.17%
Insider Own
0.73%
Insider Trans
-0.54%
Inst Own
104.29%
Inst Trans
-0.60%
ROA
25.35%
ROE
-
ROIC
41.28%
Gross Margin
57.31%
Oper. Margin
27.52%
Profit Margin
21.40%
SMA20
5.60%
SMA50
9.92%
SMA200
-1.11%
Trades
Shs Outstand
20.21M
Shs Float
20.06M
52W High
1525.17 -14.79%
52W Low
1023.05 27.03%
Volatility
2.65% 2.72%
ATR (14)
34.86
RSI (14)
63.54
Beta
1.24
Rel Volume
0.49
Avg Volume
204.43K
Volume
99,356
Perf Week
0.31%
Perf Month
14.70%
Perf Quarter
-1.92%
Perf Half Y
-11.31%
Perf YTD
-6.79%
Perf Year
6.18%
Perf 3Y
-2.12%
Perf 5Y
-9.89%
Perf 10Y
242.50%
Prev Close
1296.17
Price
1299.53
Change
0.26%
Date Action Analyst Rating Change Price Target Change
Jun-02-26Resumed Wolfe Research Peer Perform
Mar-20-26Upgrade Jefferies Hold → Buy $1450
Dec-15-25Upgrade BofA Securities Neutral → Buy $1600
Dec-09-25Initiated Goldman Neutral $1475
Dec-02-25Initiated Morgan Stanley Equal-Weight $1550
Jun-24-25Initiated Barclays Overweight $1325
May-20-25Upgrade UBS Neutral → Buy $1350
May-05-25Upgrade Jefferies Underperform → Hold $1110
May-05-25Upgrade Jefferies Underperform → Hold $1100
Apr-07-25Upgrade Citigroup Neutral → Buy $1400
Jul-06-26 04:30PM
Jun-04-26 09:58AM
May-09-26 03:03AM
May-08-26 04:30PM
May-07-26 04:37PM
04:30PM Loading…
04:30PM
May-01-26 04:30PM
Apr-09-26 04:30PM
06:30AM
Mar-12-26 06:58AM
Mar-05-26 07:31PM
09:35AM
Feb-27-26 07:52AM
Feb-24-26 02:43PM
Feb-23-26 05:04AM
11:37PM Loading…
Feb-18-26 11:37PM
10:33PM
Feb-12-26 12:40AM
Feb-06-26 09:08PM
06:30PM
04:02PM
02:20PM
01:58PM
01:46PM
Feb-05-26 05:40PM
04:49PM
04:48PM
04:30PM
Feb-04-26 09:15AM
Feb-03-26 10:10PM
09:40PM Loading…
Feb-02-26 09:40PM
Jan-26-26 09:45AM
Jan-20-26 04:30PM
08:12AM
Jan-18-26 11:35PM
Jan-12-26 08:43AM
07:36AM
Jan-09-26 04:30PM
Jan-05-26 04:30PM
Dec-16-25 09:45AM
Dec-08-25 10:37PM
06:58AM
Dec-01-25 09:50AM
Nov-28-25 09:45AM
Nov-25-25 09:00AM
Nov-24-25 08:40AM
Nov-21-25 06:50PM
Nov-20-25 04:15PM
Nov-18-25 04:30PM
Nov-13-25 11:01PM
12:36AM
Nov-07-25 09:30PM
06:35PM
04:37PM
12:51PM
Nov-06-25 06:13PM
05:45PM
04:45PM
04:30PM
Nov-04-25 10:13PM
09:15AM
07:10AM
Nov-03-25 10:00AM
Oct-30-25 10:00AM
Oct-29-25 12:01AM
Oct-23-25 07:36AM
Oct-16-25 07:25PM
Oct-09-25 11:34PM
Oct-07-25 04:30PM
Sep-29-25 09:45AM
Sep-15-25 02:01AM
Sep-08-25 07:41AM
Aug-28-25 09:45AM
Aug-27-25 08:10AM
Aug-25-25 10:20AM
Aug-15-25 09:55AM
Aug-12-25 11:51PM
11:50PM
Aug-11-25 07:43AM
Aug-07-25 09:45AM
Aug-05-25 09:50AM
Aug-04-25 04:30PM
Aug-02-25 03:06AM
Aug-01-25 06:34PM
06:00PM
12:25PM
Jul-31-25 07:21PM
05:45PM
04:40PM
04:30PM
Jul-29-25 11:05PM
09:15AM
07:14AM
Jul-28-25 10:00AM
08:41AM
Jul-24-25 10:00AM
Jul-23-25 12:10PM
Jul-22-25 09:45AM
08:15AM
Jul-18-25 07:31AM
Mettler-Toledo International, Inc. engages in the provision of precision instruments and services. The firm manufactures weighing instruments for use in laboratory, industrial, packaging, logistics, and food retailing applications. It also manufactures several related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development, metal detection and other end-of-line inspection systems used in production and packaging and provides solutions for use in certain process analytics applications. It operates through the following segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The U.S. Operations segment represents certain of the company's marketing and producing organizations located in the United States. The Swiss Operations segment is involved in the marketing and producing organizations located in Switzerland, as well as extensive research and development operations that are responsible for the development, production, and marketing of precision instruments, including weighing, analytical, and measurement technologies for use in a variety of industrial, and laboratory applications. The Western European Operations segment includes marketing and producing organizations in Western Europe, excluding operations located in Switzerland. The Chinese Operations segment focuses on marketing and producing organizations located in China. The Other Operations segment refers to the operations that exist outside these reportable segments. The company was founded in 1991 and is headquartered in Columbus, OH.
President & CEOMr. Patrick K. Kaltenbach
Chief Financial OfficerMr. Shawn P. Vadala
Chief Human Resources OfficerMs. Susan Graham-Bryce
Head of European & North American Market OrganizationsMr. Marc de La Gueronniere
Head of Asia/PacificMr. Richard Wong
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vadala ShawnChief Financial OfficerFeb 10 '26Option Exercise595.31800476,2486,088Feb 11 02:08 PM
Vadala ShawnChief Financial OfficerFeb 10 '26Sale1410.128001,128,0965,288Feb 11 02:08 PM
de la Guerroniere MarcHead of Eur & NA Market OrgsNov 25 '25Option Exercise877.336,0555,312,2566,242Nov 26 10:38 AM
de la Guerroniere MarcHead of Eur & NA Market OrgsNov 25 '25Sale1488.186,0559,010,900187Nov 26 10:38 AM
Vadala ShawnChief Financial OfficerNov 24 '25Option Exercise671.601,025688,3906,313Nov 26 10:38 AM
Vadala ShawnChief Financial OfficerNov 25 '25Option Exercise595.311,000595,3106,288Nov 26 10:38 AM
Vadala ShawnChief Financial OfficerNov 25 '25Sale1511.001,0001,511,0005,288Nov 26 10:38 AM
Vadala ShawnChief Financial OfficerNov 24 '25Sale1452.001,0251,488,3005,288Nov 26 10:38 AM
Keller GerryHead of Process AnalyticsNov 21 '25Option Exercise717.62236169,358395Nov 25 11:19 AM
Keller GerryHead of Process AnalyticsNov 21 '25Sale1418.58236334,785159Nov 25 11:19 AM
Kaltenbach PatrickPresident and CEONov 12 '25Option Exercise1024.552,0002,049,1005,670Nov 13 11:10 AM
Kaltenbach PatrickPresident and CEONov 12 '25Sale1462.502,0002,924,9983,670Nov 13 11:10 AM
Vadala ShawnChief Financial OfficerNov 11 '25Option Exercise506.251,895959,3537,183Nov 13 11:09 AM
Vadala ShawnChief Financial OfficerNov 11 '25Sale1455.521,8952,758,2125,288Nov 13 11:09 AM
de la Guerroniere MarcHead of Eur & NA Market OrgsNov 11 '25Option Exercise631.856,8804,347,1087,067Nov 13 11:09 AM
de la Guerroniere MarcHead of Eur & NA Market OrgsNov 11 '25Sale1450.006,8809,976,000187Nov 13 11:09 AM
FINNEY ELISHA WDirectorNov 10 '25Option Exercise595.31474282,177785Nov 13 11:01 AM
FINNEY ELISHA WDirectorNov 10 '25Sale1433.57474679,512311Nov 13 11:01 AM
Elisha FinneyBoard of DirectorNov 10 '25Proposed Sale1433.57474679,512Nov 10 01:34 PM
Vadala ShawnChief Financial OfficerAug 19 '25Option Exercise397.95300119,3855,395Aug 21 10:17 AM
Vadala ShawnChief Financial OfficerAug 19 '25Sale1325.00300397,5005,095Aug 21 10:17 AM
Keller GerryHead of Process AnalyticsAug 14 '25Option Exercise720.81165118,934259Aug 18 10:43 AM
Keller GerryHead of Process AnalyticsAug 14 '25Sale1308.64165215,92694Aug 18 10:43 AM
SALICE THOMAS PDirectorAug 13 '25Option Exercise312.361,062331,7261,345Aug 15 10:16 AM
SALICE THOMAS PDirectorAug 13 '25Sale1300.901,0621,381,560283Aug 15 10:16 AM
SALICE THOMAS PDirectorAug 13 '25Proposed Sale1300.901,0621,381,560Aug 13 01:08 PM
Vadala ShawnChief Financial OfficerAug 08 '25Option Exercise397.95300119,3855,395Aug 12 11:41 AM
Vadala ShawnChief Financial OfficerAug 08 '25Sale1254.09300376,2275,095Aug 12 11:41 AM